| Literature DB >> 19486532 |
Stefan Buchner1, Kurt Debl, Josef Haimerl, Behrus Djavidani, Florian Poschenrieder, Stefan Feuerbach, Guenter A J Riegger, Andreas Luchner.
Abstract
BACKGROUND: Left ventricular hypertrophy (LVH) is a hallmark of chronic pressure or volume overload of the left ventricle and is associated with risk of cardiovascular morbidity and mortality. The purpose was to evaluate different electrocardiographic criteria for LVH as determined by cardiovascular magnetic resonance (CMR). Additionally, the effects of concentric and eccentric LVH on depolarization and repolarization were assessed.Entities:
Mesh:
Year: 2009 PMID: 19486532 PMCID: PMC2696426 DOI: 10.1186/1532-429X-11-18
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
Summary of various ecg criteria used for evaluation of lvh
| Reference | Formula | Definition of LVH | |
| Sokolow-Lyon Voltage [ | SV1 + RV5 or RV6 | ≥3.5 mV | |
| Sokolow-Lyon Product [ | (SV1 + RV or RV6) * QRS | ≥371.0 mVms | |
| Gubner-Ungerleider [ | RI + SIII | ≥2.0 mV | |
| Cornell Voltage [ | RaVL + SV3 | ≥2.8 mV (men) | |
| Cornell Voltage Product [ | (RaVL + SV3) × QRS duration (men) | ≥244.0 mVms | |
| Romhilt-Estes score [ | 1. Amplitude = R or S wave in limb leads ≥2.0 mV or SV1-2 ≥3.0 mV or RV5-6 ≥3.0 mV | 3 points | ≥5 points: definite LVH |
| 2. ST-T segment pattern = | |||
| without digitalis | 3 points | ||
| with digitalis | 1 point | ||
| 3. Left atrial involment | 3 points | ||
| 4. Left axis deviation ≥-30° | 2 points | ||
| 5. QRS duration ≥0.09 sec | 1 point | ||
| 6 Intrinsicoid deflection ≥0.05 sec in V5-V6 | 1 point | ||
| Perugia score [ | SV3 + RaVL >2.4 mV (men) | At least one criterion | |
CMR characteristics in the study population
| All | Normal LV geometry | Concentric Remodeling | Concentric LVH | Eccentric LVH | ||
| N (%) | 30 | 120 (100) | 10 (8) | 8 (7) | 59 (49) | 43 (36) |
| Predominant AS (%) | - | 87 (100) | 10 (12) | 8 (9) | 53 (61) | 16 (18) |
| Predominant AR (%) | - | 33 (100) | 0 (0) | 0 (0) | 9 (27) | 24 (73) |
| EF (%) | 57 ± 6 | 57 ± 15 | 55 ± 18 | 69 ± 9 | 60 ± 14 | 50 ± 15* |
| LVM (g) | 97 ± 26 | 199 ± 72§ | 120 ± 27 | 120 ± 22 | 224 ± 77 | 199 ± 54 |
| LVEDV (ml) | 133 ± 24 | 168 ± 74§ | 131 ± 51 | 81 ± 13 | 144 ± 51 | 226 ± 72* |
| LVMI (g/m2) | 51 ± 10 | 104 ± 33§ | 64 ± 11 | 64 ± 5 | 114 ± 34 | 106 ± 26 |
| LVEDVI (ml/m2) | 72 ± 10 | 88 ± 38§ | 69 ± 21 | 44 ± 7 | 73 ± 23 | 120 ± 37* |
| M/V ratio (g/ml) | 0.76 ± 0.18 | 1.30 ± 0.45§ | 0.95 ± 0.16 | 1.48 ± 0.31 | 1.61 ± 0.38 | 0.92 ± 0.19* |
Data are presented as mean ± SD. AS, aortic stenosis; AR, aortic regurgitation; EF, ejection fraction; LVM, left ventricular mass; LVEDV, left ventricular enddiastolic volume; LVMI, left ventricular mass index; LVEDVI, left ventricular enddiastolic volume index; M/V, mass-volume ratio LVM/LVEDV; §, p < 0.05 all patients versus CTRL; *, p < 0.05 concentric LVH versus eccentric LVH.
Correlation coefficients between various electrocardiographic criteria and CMR parameters
| 0.49 | <0.001 | 0.38 | <0.001 | 0.57 | <0.001 | 0.42 | <0.001 | 0.16 | <0.05 | |
| 0.60 | <0.001 | 0.47 | <0.001 | 0.66 | <0.001 | 0.49 | <0.001 | 0.19 | <0.05 | |
| 0.32 | <0.001 | 0.20 | <0.05 | 0.33 | <0.001 | 0.18 | <0.05 | 0.21 | <0.01 | |
| 0.37 | <0.001 | 0.20 | <0.05 | 0.47 | <0.001 | 0.25 | <0.01 | 0.25 | <0.01 | |
| 0.44 | <0.001 | 0.28 | <0.01 | 0.53 | <0.001 | 0.32 | <0.001 | 0.24 | <0.01 | |
| 0.57 | <0.001 | 0.33 | <0.001 | 0.60 | <0.001 | 0.31 | <0.001 | 0.30 | <0.001 | |
LVM, LV mass; LVEDV, LV enddiastolic volume; LVM, left ventricular mass index; LVEDVI, left ventricular enddiastolic volume index; M/V, LVMI/LVEDVI ratio
Figure 1Varying overlap between 95.
ROC-analysis and predicitve values for ECG-LVH criteria to detect CMR-LVH
| 0.72 (0.64 – 0.81) | 34 | 90 | 88 | 39 | 52 | |
| 0.86 (0.79 – 0.92) | 51 | 96 | 90 | 46 | 65 | |
| 0.78 (0.70 – 0.86) | 52 | 87 | 91 | 48 | 63 | |
| 0.81 (0.73 – 0.89) | 56 | 87 | 96 | 48 | 66 | |
| 0.80 (0.73 – 0.88) | 57 | 90 | 92 | 49 | 67 | |
| 0.87 (0.80 – 0.94) | n.a. | n.a. | n.a. | n.a. | n.a. | |
| n.a. | 66 | 85 | 91 | 54 | 72 | |
| n.a. | 86 | 81 | 91 | 74 | 85 | |
| n.a. | 80 | 77 | 88 | 65 | 79 |
ROC, receiver-operating-characteristics; AUC, area under curve; CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value; ACC, accuracy; n.a., not applicable
Figure 2Sensitivities and specificities (A) and positive predictive values and negative predictive values (B) of the various ECG criteria for LVH determined by CMR.
Figure 3Significantly decreased ST-segment (A) and T-wave (B) amplitude in leads V5, V6, I and aVL between concentric and eccentric LVH (p < 0.05 for all).
Figure 4Representative CMR image and ECG of LV with (A) concentric (LV enddiastolic diameter 42 mm) and (B) eccentric LVH (LV enddiastolic diameter 60 mm).